Loading company
Cardiol Therapeutics Inc.
CRDL · Nasdaq · ·
$1.700.0%Sep 29 close
- 1M
- -12.6%
- 6M
- +38.9%
- 1Y
- +58.4%
- 5Y
- -59.9%
CRDL · Nasdaq · ·
$1.700.0%Sep 29 close
The quarter ending September 30, 2024, against the same quarter a year earlier.
| Measure | 3 months toSep 30, 2024 | 3 months toMar 31, 2022 | Change |
|---|---|---|---|
| Free Cash Flow | -$5.5M | -$7.4M | +25.44% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
The quote and the company description come from the 6-K Cardiol Therapeutics Inc. filed on August 12, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Cardiol Therapeutics Inc. has no earnings call transcript available.